Recombinant multi-species ALR/GFER protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ALR/GFER protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The hepatotrophic factor designated augmenter of liver regeneration (ALR) is thought to be one of the factors responsible for the extraordinary regenerative capacity of mammalian liver. It has also been called hepatic regenerative stimulation substance (HSS). The gene resides on chromosome 16 in the interval containing the locus for polycystic kidney disease (PKD1). The putative gene product is 42% similar to the scERV1 protein of yeast. The yeast scERV1 gene had been found to be essential for oxidative phosphorylation, the maintenance of mitochondrial genomes, and the cell division cycle. The human gene is both the structural and functional homolog of the yeast scERV1 gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ALR,Alr,Augmenter of liver regeneration (hERV1),ERV1,FAD-linked sulfhydryl oxidase ALR,GFER,Gfer,HERV1,HPO,HPO1,HPO2,HSS,Hepatopoietin,MMCHD,MPMCD

Target products collectionGo to ALR/GFER products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0943-Ag-1/ GM-Tg-hg-SE0943-Ag-2 Human ALR/GFER protein Human
GM-Tg-rg-SE0943-Ag-1/ GM-Tg-rg-SE0943-Ag-2 Rat ALR/GFER protein Rat
GM-Tg-mg-SE0943-Ag-1/ GM-Tg-mg-SE0943-Ag-2 Mouse ALR/GFER protein Mouse
GM-Tg-cynog-SE0943-Ag-1/ GM-Tg-cynog-SE0943-Ag-2 Cynomolgus/Rhesus macaque ALR/GFER protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0943-Ag-1/ GM-Tg-felg-SE0943-Ag-2 Feline ALR/GFER protein Feline
GM-Tg-cang-SE0943-Ag-1/ GM-Tg-cang-SE0943-Ag-2 Canine ALR/GFER protein Canine
GM-Tg-bovg-SE0943-Ag-1/ GM-Tg-bovg-SE0943-Ag-2 Bovine ALR/GFER protein Bovine
GM-Tg-equg-SE0943-Ag-1/ GM-Tg-equg-SE0943-Ag-2 Equine ALR/GFER protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0943-Ag-1/ GM-Tg-hg-SE0943-Ag-2; GM-Tg-rg-SE0943-Ag-1/ GM-Tg-rg-SE0943-Ag-2;
GM-Tg-mg-SE0943-Ag-1/ GM-Tg-mg-SE0943-Ag-2; GM-Tg-cynog-SE0943-Ag-1/ GM-Tg-cynog-SE0943-Ag-2;
GM-Tg-felg-SE0943-Ag-1/ GM-Tg-felg-SE0943-Ag-2; GM-Tg-cang-SE0943-Ag-1/ GM-Tg-cang-SE0943-Ag-2;
GM-Tg-bovg-SE0943-Ag-1/ GM-Tg-bovg-SE0943-Ag-2; GM-Tg-equg-SE0943-Ag-1/ GM-Tg-equg-SE0943-Ag-2
Products Name ALR/GFER protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ALR/GFER
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ALR/GFER protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.